Aspirin users with common genes may get less colon cancer: study

Researchers have identified common genetic traits that may explain how aspirin can help protect against colon cancer. The researchers pooled genetic and lifestyle data from 10 studies involving more than 17,000 people, about half had colon or rectal cancer. Overall, frequent aspirin use reduced chances of developing colo-rectal cancer by an average of about 30 per cent, compared with nonusers. The studies used different definitions of frequent use, but in most it was at least twice weekly for more than a month. Read more here.